| |
| |
|
| Insider
Information: |
Clark David C |
| Relationship: |
CHIEF FINANCIAL OFFICER |
| City: |
Westminster |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
48,933 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,632 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
48,933 |
|
|
| Total
Value |
$5,632 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Allos Therapeutics Inc |
ALTH |
VP, Finance |
2012-09-04 |
0 |
2004-12-31 |
0 |
Premium* |
|
|
Oblong, Inc. |
OBLG |
CHIEF FINANCIAL OFFICER |
2020-06-04 |
48,933 |
2013-03-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2020-06-04 |
4 |
D |
$1.07 |
$4,279 |
D/D |
(3,999) |
48,933 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2020-06-04 |
4 |
A |
$1.07 |
$12,484 |
D/D |
11,667 |
52,932 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2020-04-13 |
4 |
D |
$1.10 |
$4,399 |
D/D |
(3,999) |
41,265 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2019-05-02 |
4/A |
D |
$1.46 |
$10,638 |
D/D |
(7,286) |
45,264 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2019-05-02 |
4 |
A |
$1.46 |
$32,608 |
D/D |
22,334 |
52,550 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2019-05-02 |
4 |
D |
$1.46 |
$5,747 |
D/D |
(3,936) |
48,614 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2018-07-01 |
4 |
D |
$0.20 |
$4,114 |
D/D |
(20,568) |
302,157 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2018-04-13 |
4 |
A |
$0.21 |
$24,500 |
D/D |
116,667 |
322,725 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2018-03-14 |
4 |
D |
$0.25 |
$7,392 |
D/D |
(29,569) |
206,058 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2016-03-25 |
4 |
D |
$0.42 |
$3,914 |
D/D |
(9,320) |
235,627 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2016-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
61,257 |
244,947 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2015-03-25 |
4 |
D |
$0.99 |
$7,646 |
D/D |
(7,723) |
183,690 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2015-03-07 |
4 |
D |
$0.93 |
$12,176 |
D/D |
(13,093) |
191,413 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2015-02-04 |
4 |
A |
$1.04 |
$83,200 |
D/D |
80,000 |
204,506 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2014-05-25 |
4 |
D |
$1.60 |
$1,035 |
D/D |
(647) |
124,506 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2014-04-25 |
4 |
D |
$1.53 |
$991 |
D/D |
(648) |
125,153 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2014-03-25 |
4 |
D |
$1.81 |
$16,869 |
D/D |
(9,320) |
125,801 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2014-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
35,121 |
135,121 |
0 |
- |
|
| OBLG |
Oblong, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2013-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
VP, Finance |
• • – |
2012-09-04 |
4 |
D |
$1.82 |
$376,947 |
D/D |
(207,114) |
0 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
VP, Finance |
• – – |
2012-03-01 |
4 |
AS |
$1.50 |
$5,073 |
D/D |
(3,385) |
207,114 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
VP, Finance |
• – – |
2012-02-29 |
4 |
AS |
$1.52 |
$5,165 |
D/D |
(3,388) |
210,499 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
VP, Finance |
• – – |
2012-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
99,779 |
213,887 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
VP, Finance |
• – – |
2012-02-24 |
4 |
AS |
$1.55 |
$922 |
D/D |
(595) |
114,108 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
VP, Finance |
• – – |
2012-02-23 |
4 |
AS |
$1.57 |
$2,291 |
D/D |
(1,460) |
114,703 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
